- This event has passed.
Navigating Revised Schedule M: A roadmap for pharma MSMEs | 10th April 2025 | Agilent

The updated Schedule M requires pharmaceutical facilities to enhance their infrastructure, processes, and documentation, presenting both challenges and opportunities, particularly for MSMEs in the pharma sector. In response, Express Pharma is hosting a webinar titled ‘Navigating Revised Schedule M: A Roadmap for Pharma MSMEs’. This event will feature industry experts who will provide guidance on compliance strategies. Attendees will gain practical insights into the revised regulations, their impact on small and medium-sized pharma manufacturers, and strategies for financing the necessary upgrades to meet compliance requirements.
Key topics for discussion:
+ Key changes and compliance requirements for pharma MSMEs
+ Practical insights on upgrading infrastructure, quality systems, and documentation
+ Role of digital transformation and technology in achieving compliance
+ Exploring government schemes, subsidies, and grants for MSMEs
+ Opportunities for loans and funding
+ Complying with the latest requirements with cost-effective latest technologies
Why attend?
Gain a clear understanding of:
+ How to align operations with the revised Schedule M
+ Best practices to streamline implementation
+ Financial avenues to support upgradation efforts
+ Technology to purchase while preserving the capex budget and complying to the latest regulatory requirements
Speakers:
♦ Kuldeep Sharma (Ph.D), Sales Development Manager- Pharmaceuticals Markets (India)
♦ Sandeep Soni, Leasing and Financing Specialist – Agilent India
♦ Mr Daara Patel, Secretary-General, Indian Drug Manufacturers Association (IDMA)
♦ Ms Aditi Kare Panandikar, Managing Director, Indoco Remedies
♦ Mr S M Mudda, Managing Director, Misom Labs